DOYLE THOMAS JAMES (CIK 1910331) reported 14 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-01-27). Recent activity: Sell KURA (1,114 shares), Sell KURA (2,226 shares), Sell KURA (695 shares), Sell KURA (2,226 shares), Sell KURA (881 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-01-27 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 1,114 | $9,424 |
| 2026-01-27 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 2,226 | $18,832 |
| 2026-01-27 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 695 | $5,880 |
| 2026-01-27 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 2,226 | $18,832 |
| 2026-01-27 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 881 | $7,453 |
| 2026-01-06 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Buy | 21,250 | $0 |
| 2025-11-14 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Buy | 24,967 | $0 |
| 2025-11-14 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 4,539 | $50,746 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Buy | 24,966 | $0 |
| 2025-09-29 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 4,541 | $40,597 |
| 2025-01-28 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 2,241 | $17,637 |
| 2025-01-28 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 887 | $6,981 |
| 2025-01-28 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 699 | $5,501 |
| 2025-01-28 | Kura Oncology, Inc. (KURA) | SVP, Finance & Accounting | Sell | 1,122 | $8,830 |
Source: SEC Form 4 filings · as of 2026-01-27